Carl Virtanen

6.9k citations
56 papers · 2.7k indexed · h-index 27
Topics
Ovarian cancer diagnosis and treatment (10 papers)Cancer-related molecular mechanisms research (6 papers)Epigenetics and DNA Methylation (5 papers)

In The Last Decade

Carl Virtanen

54 papers receiving 2.7k citations

Peers

Carl Virtanen
Comparison fields: 5 of 139
  • Molecular Biology 1.5k
  • Oncology 556
  • Cancer Research 456
  • Genetics 446
  • Immunology 314
Replace Emily O. Kistner with:
Emily O. Kistner United States
Angela Brooks‐Wilson Canada
Joanne Ngeow Singapore
Saleh Altuwaijri Saudi Arabia
Yulin Liu China
He Yu Canada
Trivadi S. Ganesan India
J F Smyth United Kingdom
Jorge Andrade United States
Xiaohua Yan China
Carl Virtanen relative to Emily O. Kistner United States Emily O. Kistner's profile →
Citations per field
00.5×2.7×
Emily O. Kistner · 1×
Citations per year

Countries citing papers authored by Carl Virtanen

Since Specialization
Citations

This map shows the geographic impact of Carl Virtanen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Carl Virtanen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Carl Virtanen more than expected).

Fields of papers citing papers by Carl Virtanen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Carl Virtanen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Carl Virtanen. The network helps show where Carl Virtanen may publish in the future.

Co-authorship network of co-authors of Carl Virtanen

This figure shows the co-authorship network connecting the top 25 collaborators of Carl Virtanen. A scholar is included among the top collaborators of Carl Virtanen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Carl Virtanen. Carl Virtanen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 0
2 7
3 15
4 18
5 3
6 8
7 19
8 29
9 0
10 29
11 20
12 91
13 44
14 11
15 34
16 53
17 30
18 66
19 17
20 79

About Carl Virtanen

Carl Virtanen is a scholar working on Reproductive Medicine, Health Informatics and Cancer Research, having authored 56 papers that have together received 2.7k indexed citations. Recurring topics across this work include Ovarian cancer diagnosis and treatment (10 papers), Cancer-related molecular mechanisms research (6 papers) and Epigenetics and DNA Methylation (5 papers). The work is most often cited by research in Cancer Research (456 citations), Reproductive Medicine (208 citations) and Molecular Biology (1.5k citations). Carl Virtanen has collaborated with scholars based in Canada, United States and United Kingdom. Frequent co-authors include Benjamin G. Neel, Sun-Chong Wang, Artūras Petronis, Hitoshi Nomura, Michael H. Jones, Yuichi Ishikawa, Tatsu Miyoshi, Azin Sayad, Theodore J. Brown and Curt Tysk. Their work appears in journals such as Cell, Proceedings of the National Academy of Sciences and The Lancet.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026